Authors:
Del Rosso, A
Pignone, A
Giacomelli, R
Cerinic, MM
Citation: A. Del Rosso et al., Familial scleroderma: Do environmental factors, genes and microchimerism share the same relevance?, J EUR A D V, 15(1), 2001, pp. 11-14
Citation: A. Pignone et al., Prostaglandin E-1 restores the levels of vWF and ACE in chronic critical limb ischemia in systemic sclerosis, CLIN EXP RH, 19(3), 2001, pp. 358-359
Citation: Al. Herrick et Mm. Cerinic, The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis, CLIN EXP RH, 19(1), 2001, pp. 4-8
Authors:
Simonini, G
Cerinic, MM
Cimaz, R
Anichini, M
Cesaretti, S
Zoppi, M
Generini, S
Falcini, F
Citation: G. Simonini et al., Evidence for immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis, J RHEUMATOL, 28(1), 2001, pp. 198-203
Authors:
Simonini, G
Pignone, A
Generini, S
Falcini, F
Cerinic, MM
Citation: G. Simonini et al., Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis (vol 155, pg 1, 2000), TOXICOLOGY, 162(1), 2001, pp. 69-69
Authors:
Della Rossa, A
Valentini, G
Bombardieri, S
Bencivelli, W
Silman, AJ
D'Angelo, S
Cerinic, MM
Belch, JF
Black, CM
Becvar, R
Bruhlman, P
Cozzi, F
Czirjak, L
Drosos, AA
Dziankowska, B
Ferri, C
Gabrielli, A
Giacomelli, R
Hayem, G
Inanc, M
McHugh, NJ
Nielsen, H
Scorza, R
Tirri, E
van den Hoogen, FHJ
Vlachoyiannopoulos, PG
Citation: A. Della Rossa et al., European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres, ANN RHEUM D, 60(6), 2001, pp. 585-591
Authors:
Valentini, G
Della Rossa, A
Bombardieri, S
Bencivelli, W
Silman, AJ
D'Angelo, S
Cerinic, MM
Belch, JF
Black, CM
Bruhlmann, P
Czirjak, L
De Luca, A
Drosos, AA
Ferri, C
Gabrielli, A
Giacomelli, R
Hayem, G
Inanc, M
McHugh, NJ
Nielsen, H
Rosada, M
Scorza, R
Stork, J
Sysa, A
van den Hoogen, FHJ
Vlachoyiannopoulos, PJ
Citation: G. Valentini et al., European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes, ANN RHEUM D, 60(6), 2001, pp. 592-598
Authors:
Falcini, F
Azzari, C
Gelli, VAMG
Luchetti, M
Gabrielli, A
Calzolari, A
Pignone, A
Generini, S
Cerinic, MM
Citation: F. Falcini et al., Reduction of bcl-2 in T cells during immunosuppressive therapy in patientswith severe juvenile onset systemic lupus erythematosus, CLIN IMMUNO, 93(1), 1999, pp. 59-64
Citation: S. Knupp-oliveira et Mm. Cerinic, Polyneuropathy as initial manifestation of systemic sclerosis (scleroderma), SC J RHEUM, 28(4), 1999, pp. 260-261
Authors:
Cerinic, MM
Generini, S
Pignone, A
Cagnoni, M
Citation: Mm. Cerinic et al., From Raynaud's phenomenon to systemic sclerosis (scleroderma): Lack or exhaustion of adaptation?, ADV ORG BIO, 6, 1998, pp. 241-253